Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway.
University of Copenhagen, Copenhagen, Denmark.
Osteoporos Int. 2021 May;32(5):873-881. doi: 10.1007/s00198-020-05739-9. Epub 2020 Nov 17.
Low vitamin D in patients with hip fracture is common. In the present study, 407 of 872 (47%) patients had serum calcidiol less than 50 nmol/L. Patients with low vitamin D had more delirium, more new hip fractures, and more medical readmissions, but not more orthopedic complications after 1 year.
We wanted to study the relation between vitamin D level and postoperative orthopedic and medical complications in patients with hip fracture. In addition, we investigated the effect of giving a single-dose cholecalciferol 100.000 IU.
Data were taken from the local hip fracture register. Logistic regression analyses including vitamin D level and potentially confounding variables were performed for complications and readmissions.
A total of 407 (47%) of 872 included hip fractures had low vitamin D at baseline. A total of 155 (18%) developed delirium, and the risk was higher in vitamin D-deficient patients (odds ratio (OR) 1.48, 95% confidence interval (CI) 1.04 to 2.12; p = 0.03). A total of 261 (30%) were readmitted for non-hip-related conditions. Low vitamin D was associated with a higher risk of medical readmissions within 30 days (OR 1.64 (1.03 to 2.61); p = 0.036) and 12 weeks (OR 1.47 (95% CI 1.02 to 2.12); p = 0.039). There was a higher risk of a new hip fracture (OR 2.84 (95% CI 1.15 to 7.03) p = 0.024) in vitamin D-deficient patients. A total of 105 (12%) developed at least one orthopedic complication, with no correlation to baseline vitamin D. Among vitamin D-deficient patients, those receiving a single-dose of 100.000 IU cholecalciferol had fewer orthopedic complications (OR 0.32 (95% CI 0.11 to 0.97) p = 0.044) the first 30 days after surgery.
Low vitamin D at admission for hip fracture increased the risk of delirium, a new hip fracture, and medical readmissions, but not orthopedic complications. The role of vitamin D supplementation to prevent orthopedic complications requires further study.
我们旨在研究髋部骨折患者的维生素 D 水平与术后骨科和内科并发症之间的关系。此外,我们还研究了给予单次剂量胆钙化醇 100000IU 的效果。
数据取自当地髋部骨折登记处。对并发症和再入院进行了包括维生素 D 水平和潜在混杂变量的逻辑回归分析。
在纳入的 872 例髋部骨折中,共有 407 例(47%)基线时维生素 D 水平较低。共有 155 例(18%)发生谵妄,维生素 D 缺乏患者的风险更高(优势比[OR]1.48,95%置信区间[CI]1.04 至 2.12;p=0.03)。共有 261 例(30%)因非髋部相关疾病再入院。维生素 D 水平较低与 30 天内内科再入院的风险较高相关(OR 1.64(1.03 至 2.61);p=0.036)和 12 周时(OR 1.47(95%CI 1.02 至 2.12);p=0.039)。维生素 D 缺乏患者新发髋部骨折的风险较高(OR 2.84(95%CI 1.15 至 7.03)p=0.024)。共有 105 例(12%)发生至少 1 例骨科并发症,与基线维生素 D 无相关性。在维生素 D 缺乏的患者中,接受单次 100000IU 胆钙化醇治疗的患者在手术后的前 30 天内发生的骨科并发症较少(OR 0.32(95%CI 0.11 至 0.97)p=0.044)。
髋部骨折入院时维生素 D 水平低会增加谵妄、新发髋部骨折和内科再入院的风险,但不会增加骨科并发症的风险。维生素 D 补充预防骨科并发症的作用需要进一步研究。